NCT00575133Recruiting
Prospective Cohort Study in Patients With NAFLD
Multicentric, Prospective, Non-interventional, Long-term Cohort Study in Patients With Non-alcoholic Fatty Liver Disease (NAFLD)
Source: ClinicalTrials.gov · Last updated 24 Feb 2012 · Not updated for over 12 months - ask the site whether it is still open
Brief summary (registry, in English)
To assess the importance of intracellular signalling pathways and its deregulation in adiposity and diabetes-related insulin resistance, liver tissue samples of patients suffering from non-alcoholic fatty liver disease (NAFLD) and non-alcoholic steatohepatitis (NASH)will be analyzed prospectively from a liver tissue bank.
- Status (registry)
- Recruiting
- Study type
- Observational
- Enrollment
- 150 (estimated)
- First submitted
- 26 Nov 2007
- Start date
- 1 Dec 2007
- Lead sponsor
- University of Zurich
- Diseases
- Fatty liver disease (MASLD/MASH)
- NCT number
- NCT00575133
What you commit to
- Study type: Observational
- Planned participants: 150
- 1 site in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Prior treatment
- Hepatotoxic medication (e.g. amiodarone).
Other illness
- History of significant alcohol consumption
- Viral hepatitis
- Autoimmune hepatitis
- Metabolic diseases (e.g. hemochromatosis, M. Wilson, alpha 1-antitrypsin deficiency)
Who the study is looking for
- Patients with histologically confirmed fatty liver disease
Age in the registry: 18 years to - · Sex: All · Does not accept healthy volunteers
Sites (1)
Sites in registry order. Pick your city on the disease page to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| University Hospital Zurich, Endocrinology and Diabetology Coordinator of this site? Confirm its status | Zurich | Switzerland | Recruiting |
This page is information, not medical advice. Discuss any trial with your doctor.